Corrigendum to: Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials
2023-01-21 13:26WeiLuZhenyuYngZuolingQiXionnYng
Wei Lu ,Zhenyu Yng ,Zuoling Qi ,Xionn Yng,*
a Plastic Surgery Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100000,China
b Department of Hemangioma and Vascular Malformation,Plastic Surgery Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100000,China
Correction for “Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials” by Lu W et al.,Chin J Plast Reconstr Surg,2022;4(3):133-139.doi:10.1016/j.cjprs.2022.08.007.
The authors regret the omission of funding information for the original article.An“Acknowledgments”section has been added at the bottom of the paper.The content now reads as follows:
Acknowledgments
This study was supported by the National Program for Multidisciplinary Cooperative Treatment on Major Disease (grant no.1112320139).
Chinese Journal of Plastic and Reconstructive Surgery2022年4期
- Chinese Journal of Plastic and Reconstructive Surgery的其它文章
- Comprehensive pathogenesis and clinical therapy in striae distensae: An overview and current perspective
- Rhinoplasty in China: A review of the most important events in its history of development
- A combined therapy for the repair of alar defects that consists of a modified spiral flap and postoperative nasal stent
- DeepPurpose-based drug discovery in chondrosarcoma
- Micropunch grafting for healing of refractory chronic venous leg ulcers
- Oral health-related quality of life between Chinese and American orthodontic patients: A two-center cross-sectional study